LYCA 10% Owner Reports $35M Purchase
The scale of the reported purchase by a major owner is a meaningful bullish signal, although the filing alone does not establish the buyer's rationale or future performance.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The scale of the reported purchase by a major owner is a meaningful bullish signal, although the filing alone does not establish the buyer's rationale or future performance.
What happened, with direct paths to the underlying reporting
Venrock Healthcare Capital Partners III, a 10% owner, reported purchasing 1,944,444 LYCA shares for about $35 million at $18 per share.
Insider: Venrock Healthcare Capital Partners III, L.P.
Role: 10 percent owner
Transaction: P-Purchase
Shares: 1,944,444
Price: $18
Value: $34,999,992
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.